US6015424A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Apparatus and method for vascular embolization
Assignee: MicroVention Inc
•
Filing: 1998-04-28
•
Granted: 2000-01-18
•
Expires: 2018-04-28
Abstract
Abstract Apparatus for vascular embolization, deployable through a microcatheter, includes a flexible, elongate deployment tube dimensioned for insertion through the microcatheter, and a filamentous embolic device releasably attached to the distal end of the tube. The embolic device is controllably transformable from a soft, compliant state to a rigid or semi-rigid state. The embolic device may include a polymeric material that is transformable by contact with vascular blood or with a liquid that is cooler than vascular blood, or it may include a metallic material that is transformable by electrolytic corrosion. The embolic device may be a continuous filamentous polymeric extrusion; an elongate microcoil filled with polymeric material; an elongate, multi-segmented chain including polymeric interconnecting portions; or an elongate chain of metal segments that are fused together by electrolytic corrosion. An aneurysm is embolized with this apparatus by deploying a microcatheter so that its distal end is adjacent the aneurysm; deploying the embolic device through the microcatheter and into the aneurysm so that the embolic device forms a web-like mass in the aneurysm; and transforming the embolic device from its soft, compliant state to its rigid or semi-rigid state. The embolic device is advantageously deployed by releasably attaching it to a flexible, elongate deployment tube that is passed through the microcatheter, and then detaching the embolic device from the tube when the embolic device is suitably situated.
Inventors
- 👤 Robert F. Rosenbluth
- 👤 Brian J. Cox
- 👤 George R. Greene, Jr.
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-02 22:48
CPC Classifications
A; A61; A61B; A61B17/00; A61B17/12; A61B17/12022; A61B17/12099; A61B17/12109; A61B17/12113; A61B17/12131; A61B17/1214; A61B17/12163; A61B17/12181; A61B17/12186; A61B17/12195; A61B2017/1205; A61B2017/12054; A61B2017/12063
Claims Analysis
Total Claims: 37
Claim 1
Independent Claim
77 words
Apparatus for vascular embolization that is deployable through a microcatheter having an axial lumen, comprising: a flexible, elongate, hollow deployment tube dimensioned for insertion through the lumen of the microcatheter, the deployment tube having a proximal end and a distal end; and a filamentous embolic device having a proximal end releasably attached to the distal end of the deployment tube, the embolic device being controllably transformable from a soft, compliant state to a rigid or semi-rigid state.
Claim 2
Dependent Claim
77 words
Apparatus for vascular embolization that is deployable through a microcatheter having an axial lumen, comprising: a flexible, elongate, hollow deployment tube dimensioned for insertion through the lumen of the microcatheter, the deployment tube having a proximal end and a distal end; and a filamentous embolic device having a proximal end releasably attached to the distal end of the deployment tube, the embolic device being controllably transformable from a soft, compliant state to a rigid or semi-rigid state.
Claim 3
Dependent Claim
28 words
The apparatus of claim 1, wherein the embolic device includes a polymeric material that is controllably transformable from a soft, compliant state to a rigid or semi-rigid state.
Claim 4
Dependent Claim
16 words
The apparatus of claim 2, wherein the polymeric material is transformable by contact with vascular blood.
Claim 5
Dependent Claim
24 words
The apparatus of claim 2, wherein the polymeric material is controllably transformable by contact with a biocompatible liquid that is cooler than vascular blood.
Claim 6
Dependent Claim
21 words
The apparatus of claim 3, wherein the polymeric material is mixed with a biocompatible plasticizer that is soluble in vascular blood.
Claim 7
Dependent Claim
14 words
The apparatus of claim 3, wherein the polymeric material includes a microcrystalline wax composition.
Claim 8
Dependent Claim
22 words
The apparatus of claim 5, wherein the polymeric material is selected from the group consisting of cellulose acetate polymers and polyurethane-based copolymers.
Claim 9
Dependent Claim
20 words
The apparatus of claim 7, wherein the plasticizer is selected from a group consisting of dimethylsulfoxide, ethyl lactate, and ethanol.
Claim 10
Independent Claim
21 words
The apparatus of any of claims 2 through 8, wherein the embolic device comprises a continuous extrusion of the polymeric material.
Claim 11
Dependent Claim
22 words
The apparatus of claim 3, wherein the embolic device comprises an elongate, flexible microcoil having a hollow interior containing the polymeric material.
Claim 12
Independent Claim
36 words
The apparatus of any of claims 2 through 8, wherein the embolic device comprises an elongate, flexible chain of multiple interlinked segments, at least some of which include an interlinking portion made of the polymeric material.
Claim 13
Dependent Claim
27 words
The apparatus of claim 1, wherein the embolic device comprises an elongate, flexible chain of multiple interlinked metal segments, wherein the chain is transformable by electrolytic corrosion.
Claim 14
Dependent Claim
26 words
The apparatus of any of claim 3, wherein the embolic device comprises an elongate, flexible chain of multiple interlinked hollow segments filled with the polymeric material.
Claim 15
Independent Claim
13 words
The apparatus of claims 10 or 13, wherein the polymeric material is cyanoacrylate.
Claim 16
Dependent Claim
24 words
A vascular embolization device, comprising: an elongate filamentous element that is controllably transformable from a soft, compliant state to a rigid or semi-rigid state.
Claim 17
Dependent Claim
24 words
A vascular embolization device, comprising: an elongate filamentous element that is controllably transformable from a soft, compliant state to a rigid or semi-rigid state.
Claim 18
Dependent Claim
31 words
The device of claim 15, wherein the device includes a portion formed of a polymeric material that is controllably transformable from a soft, compliant state to a rigid or semi-rigid state.
Claim 19
Dependent Claim
16 words
The device of claim 16, wherein the polymeric material is transformable by contact with vascular blood.
Claim 20
Dependent Claim
24 words
The device of claim 16, wherein the polymeric material is controllably transformable by contact with a biocompatible liquid that is cooler than vascular blood.
Claim 21
Dependent Claim
21 words
The device of claim 17, wherein the polymeric material is mixed with a biocompatible plasticizer that is soluble in vascular blood.
Claim 22
Dependent Claim
14 words
The device of claim 17, wherein the polymeric material includes a microcrystalline wax composition.
Claim 23
Dependent Claim
22 words
The device of claim 19, wherein the polymeric material is selected from the group consisting of cellulose acetate polymers and polyurethane-based copolymers.
Claim 24
Dependent Claim
20 words
The device of claim 21, wherein the plasticizer is selected from a group consisting of dimethylsulfoxide, ethyl lactate, and ethanol.
Claim 25
Independent Claim
21 words
The device of any of claims 16 through 22, wherein the filamentous element comprises a continuous extrusion of the polymeric material.
Claim 26
Dependent Claim
22 words
The device of claim 17, wherein the filamentous element comprises an elongate, flexible microcoil having a hollow interior containing the polymeric material.
Claim 27
Independent Claim
36 words
The device of any of claims 16 through 22, wherein the filamentous element comprises an elongate, flexible chain of multiple interlinked segments, at least some of which include an interlinking portion made of the polymeric material.
Claim 28
Dependent Claim
27 words
The device of claim 15, wherein the filamentous element comprises an elongate, flexible chain of multiple interlinked metal segments, wherein the chain is transformable by electrolytic corrosion.
Claim 29
Dependent Claim
23 words
The device claim 17, wherein the filamentous element comprises an elongate, flexible chain of multiple interlinked hollow segments filled with the polymeric material.
Claim 30
Independent Claim
13 words
The apparatus of claims 24 or 27, wherein the polymeric material is cyanoacrylate.
Claim 31
Independent Claim
90 words
A method of embolizing a vascular site, comprising the steps of: (a) deploying a catheter so that its distal end is adjacent the vascular site; (b) providing an elongate, filamentous embolic device that is controllably transformable from a soft, compliant state to a rigid or semi-rigid state; (c) deploying the embolic device through the catheter and into the vascular site so that the embolic device forms a web-like mass in the vascular site; and (d) transforming the embolic device from its soft, compliant state to its rigid or semi-rigid state.
Claim 32
Independent Claim
90 words
A method of embolizing a vascular site, comprising the steps of: (a) deploying a catheter so that its distal end is adjacent the vascular site; (b) providing an elongate, filamentous embolic device that is controllably transformable from a soft, compliant state to a rigid or semi-rigid state; (c) deploying the embolic device through the catheter and into the vascular site so that the embolic device forms a web-like mass in the vascular site; and (d) transforming the embolic device from its soft, compliant state to its rigid or semi-rigid state.
Claim 33
Dependent Claim
120 words
The method of claim 29, wherein the embolic device has a proximal end and a distal end, and wherein the step of deploying comprises the steps of: (c)(1) providing an elongate, flexible deployment tube having a distal end; (c)(2) attaching the proximal end of the embolic device to the distal end of the deployment tube; (c)(3) inserting the distal end of the deployment tube into the catheter; and (c)(4) pushing the deployment tube though the catheter with the assistance of a fluid flowing through the catheter so as to carry the deployment tube and the embolic device through the catheter until the embolic device is deployed in the vascular site; and (c)(5) detaching the embolic device from the deployment tube.
Claim 34
Independent Claim
53 words
The method of claims 29 or 30, wherein the embolic device includes a portion made of a polymeric material that is transformable from the soft compliant state to the rigid or semi-rigid state, and wherein the step of transforming is performed by contacting the polymeric portion of the embolic device with vascular blood.
Claim 35
Independent Claim
60 words
The method of claims 29 or 30, wherein the embolic device includes a portion made of a polymeric material that is transformable from the soft, compliant state to the rigid or semi-rigid state, and wherein the step of transforming is performed by contacting the polymeric portion of the embolic device with a biocompatible liquid that is cooler than vascular blood.
Claim 36
Independent Claim
35 words
The method of claims 29 or 30, wherein the embolic device comprises an elongate, flexible chain of multiple interlinked metal segments, and wherein the step of transforming is performed by electrolytic corrosion of the segments.
Claim 37
Independent Claim
78 words
The method of claims 29 or 30, wherein the embolic device has a hollow interior, and wherein the step of transforming includes the steps of: (d)(1) injecting a transition material into the interior of the embolic device, the transition material being transformable from a flowable state to a rigid or semi-rigid state by contact with vascular blood; and (d)(2) transforming the transition material from the flowable state to the rigid or semi-rigid state through contact with vascular blood.
References Cited (Backward Citations)
US4551132A
Cited
US4795741A
Cited
US4819637A
Cited
US4994069A
Cited
US5163952A
Cited
US5133731A
Cited
US5226911A
Cited
US5624685A
Cited
US5469867A
Cited
US5443478A
Cited
US5312415A
Cited
US5382259A
Cited
US5382260A
Cited
US5476472A
Cited
US5350397A
Cited
US5718711A
Cited
US5612050A
Cited
US5525334A
Cited
WO1997026939A1
Cited
US5578074A
Cited
US5634936A
Cited
US5645558A
Cited
US5624461A
Cited
US5725568A
Cited
US5582619A
Cited
US5580568A
Cited
US5658308A
Cited
US5749894A
Cited
WO1997027888A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2003-01-17 | 2003-07-19 | 2004-01-18 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2007-01-17 | 2007-07-19 | 2008-01-18 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2011-01-17 | 2011-07-19 | 2012-01-18 | $7700.00 | Window Closed / Lapsed |